COVID-19 Mortality Higher for Leukemia, Myelodysplastic Syndrome Patients
By Lori Solomon HealthDay Reporter
THURSDAY, Nov. 21, 2024 -- The risk for COVID-19 hospitalization is low in adults with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), but these individuals have a high mortality risk, according to a study published online Oct. 16 in Frontiers in Oncology.
Barath Prashanth Sivasubramanian, M.D., from the Northeast Georgia Medical Center in Gainesville, and colleagues investigated mortality among AML and MDS patients with COVID-19. The analysis included data from 28,028 AML admissions and 28,148 MDS admissions identified from the National Inpatient Sample (2020 to 2021).
The researchers found that 1.2 percent of AML patients were admitted for COVID-19, and the AML-COVID-19 cohort had a lower hospitalization risk (adjusted odds ratio, 0.3) and higher mortality (21.7 versus 8.7 percent) versus AML patients admitted for other causes. Following hematopoietic stem cell transplantation (HSCT), AML patients had a higher risk for COVID-19 (20.2 versus 9.8 percent) and increased mortality (19.1 versus 6.7 percent) versus other causes. Among MDS patients, 2.7 percent were admitted for COVID-19, with the MDS-COVID-19 cohort having a lower hospitalization risk (adjusted odds ratio, 0.59) and higher mortality (19.6 versus 6.6 percent) versus other causes. HSCT did not alter the risk for COVID-19 hospitalizations in MDS patients (3 versus 3.9 percent), but these patients had higher mortality (17.4 versus 5.1 percent).
"These findings underscore the need for close monitoring and implementation of preventive strategies," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Further Support and Information on COVID-19
Read this next
Doctors' Preferences for Their Own End-of-Life Care? No Life-Sustaining Practices
FRIDAY, June 13, 2025 -- Many physicians would personally prefer to avoid life-sustaining practices if they had advanced cancer or Alzheimer disease, according to a study...
Mindfulness, Transcranial Stimulation Promising for Urgency Urinary Incontinence
FRIDAY, June 13, 2025 -- Mindfulness (MI) and transcranial direct current stimulation (tDCS) of the dorsolateral prefrontal cortex offer therapeutic benefit for reducing...
Most TikTok Videos on Inflammatory Bowel Disease Are Low Quality
FRIDAY, June 13, 2025 -- The most-viewed inflammatory bowel disease (IBD) videos on TikTok provide low-quality medical information, according to a study published online in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.